These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36418896)

  • 1. Polymeric micelles effectively reprogram the tumor microenvironment to potentiate nano-immunotherapy in mouse breast cancer models.
    Panagi M; Mpekris F; Chen P; Voutouri C; Nakagawa Y; Martin JD; Hiroi T; Hashimoto H; Demetriou P; Pierides C; Samuel R; Stylianou A; Michael C; Fukushima S; Georgiou P; Papageorgis P; Papaphilippou PC; Koumas L; Costeas P; Ishii G; Kojima M; Kataoka K; Cabral H; Stylianopoulos T
    Nat Commun; 2022 Nov; 13(1):7165. PubMed ID: 36418896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity.
    Panagi M; Voutouri C; Mpekris F; Papageorgis P; Martin MR; Martin JD; Demetriou P; Pierides C; Polydorou C; Stylianou A; Louca M; Koumas L; Costeas P; Kataoka K; Cabral H; Stylianopoulos T
    Theranostics; 2020; 10(4):1910-1922. PubMed ID: 32042344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pirfenidone-Loaded Polymeric Micelles as an Effective Mechanotherapeutic to Potentiate Immunotherapy in Mouse Tumor Models.
    Mpekris F; Papaphilippou PC; Panagi M; Voutouri C; Michael C; Charalambous A; Marinov Dinev M; Katsioloudi A; Prokopi-Demetriades M; Anayiotos A; Cabral H; Krasia-Christoforou T; Stylianopoulos T
    ACS Nano; 2023 Dec; 17(24):24654-24667. PubMed ID: 38054429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior anti-CAFs break down the CAFs barrier and improve accumulation of docetaxel micelles in tumor.
    Pang N; Li J; Sun A; Yang Z; Cheng S; Qi XR
    Int J Nanomedicine; 2018; 13():5971-5990. PubMed ID: 30323586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between cancer-associated fibroblasts and immune cells in peritoneal metastasis: inhibition in the migration of M2 macrophages and mast cells by Tranilast.
    Nakamura Y; Kinoshita J; Yamaguchi T; Aoki T; Saito H; Hamabe-Horiike T; Harada S; Nomura S; Inaki N; Fushida S
    Gastric Cancer; 2022 May; 25(3):515-526. PubMed ID: 34997450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranilast inhibits the function of cancer-associated fibroblasts responsible for the induction of immune suppressor cell types.
    Ohshio Y; Hanaoka J; Kontani K; Teramoto K
    Scand J Immunol; 2014 Dec; 80(6):408-16. PubMed ID: 25224016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug repositioning of tranilast to sensitize a cancer therapy by targeting cancer-associated fibroblast.
    Ochi K; Suzawa K; Thu YM; Takatsu F; Tsudaka S; Zhu Y; Nakata K; Takeda T; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Shien T; Okamoto Y; Tomida S; Toyooka S
    Cancer Sci; 2022 Oct; 113(10):3428-3436. PubMed ID: 35871750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectively targeting tumor-associated macrophages and tumor cells with polymeric micelles for enhanced cancer chemo-immunotherapy.
    Wei X; Liu L; Li X; Wang Y; Guo X; Zhao J; Zhou S
    J Control Release; 2019 Nov; 313():42-53. PubMed ID: 31629039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of Micelles Encapsulating Doxorubicin and Their Anticancer Effect in Combination With Tranilast in 3D Spheroids and
    Nii T; Yoshikawa K; Takeuchi I; Makino K
    Anticancer Res; 2022 Jun; 42(6):2847-2857. PubMed ID: 35641258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranilast-induced stress alleviation in solid tumors improves the efficacy of chemo- and nanotherapeutics in a size-independent manner.
    Papageorgis P; Polydorou C; Mpekris F; Voutouri C; Agathokleous E; Kapnissi-Christodoulou CP; Stylianopoulos T
    Sci Rep; 2017 Apr; 7():46140. PubMed ID: 28393881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated macrophage membrane-camouflaged pH-responsive polymeric micelles for combined cancer chemotherapy-sensitized immunotherapy.
    Du T; Wang Y; Luan Z; Zhao C; Yang K
    Int J Pharm; 2022 Aug; 624():121911. PubMed ID: 35700870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranilast inhibits cell proliferation and migration and promotes apoptosis in murine breast cancer.
    Subramaniam V; Chakrabarti R; Prud'homme GJ; Jothy S
    Anticancer Drugs; 2010 Apr; 21(4):351-61. PubMed ID: 20145538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano-Immune-Engineering Approaches to Advance Cancer Immunotherapy: Lessons from Ultra-pH-Sensitive Nanoparticles.
    Li S; Bennett ZT; Sumer BD; Gao J
    Acc Chem Res; 2020 Nov; 53(11):2546-2557. PubMed ID: 33063517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy.
    Chauhan VP; Chen IX; Tong R; Ng MR; Martin JD; Naxerova K; Wu MW; Huang P; Boucher Y; Kohane DS; Langer R; Jain RK
    Proc Natl Acad Sci U S A; 2019 May; 116(22):10674-10680. PubMed ID: 31040208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversing activity of cancer associated fibroblast for staged glycolipid micelles against internal breast tumor cells.
    Zhu Y; Yu F; Tan Y; Hong Y; Meng T; Liu Y; Dai S; Qiu G; Yuan H; Hu F
    Theranostics; 2019; 9(23):6764-6779. PubMed ID: 31660067
    [No Abstract]   [Full Text] [Related]  

  • 17. Prodrug polymeric micelles integrating cancer-associated fibroblasts deactivation and synergistic chemotherapy for gastric cancer.
    Zheng S; Wang J; Ding N; Chen W; Chen H; Xue M; Chen F; Ni J; Wang Z; Lin Z; Jiang H; Liu X; Wang L
    J Nanobiotechnology; 2021 Nov; 19(1):381. PubMed ID: 34802453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normalizing the Microenvironment Overcomes Vessel Compression and Resistance to Nano-immunotherapy in Breast Cancer Lung Metastasis.
    Mpekris F; Panagi M; Voutouri C; Martin JD; Samuel R; Takahashi S; Gotohda N; Suzuki T; Papageorgis P; Demetriou P; Pierides C; Koumas L; Costeas P; Kojima M; Ishii G; Constantinidou A; Kataoka K; Cabral H; Stylianopoulos T
    Adv Sci (Weinh); 2021 Feb; 8(3):2001917. PubMed ID: 33552852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer.
    Zou R; Jiang Q; Jin T; Chen M; Yao L; Ding H
    Front Immunol; 2022; 13():956224. PubMed ID: 36032075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymeric micelles and cancer therapy: an ingenious multimodal tumor-targeted drug delivery system.
    Hari SK; Gauba A; Shrivastava N; Tripathi RM; Jain SK; Pandey AK
    Drug Deliv Transl Res; 2023 Jan; 13(1):135-163. PubMed ID: 35727533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.